✦ LIBER ✦

Is additional neurohormonal antagonism useful in patients with severe chronic heart failure already receiving a combination of neurohormonal antagonists? Results of the COPERNICUS study

✍ Scribed by Henry Krum; Paul Mohacsi; Hugo A. Katus; Michal Tendera; Jean L. Rouleau; Michael B. Fowler; Andrew J. Coats; Ellen B. Roecker; Milton Packer

Book ID: 119544334
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 316 KB
Volume: 39
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)80786-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is additional neurohormonal antagonism u

Is additional neurohormonal antagonism useful in patients with severe chronic heart failure already receiving a combination of neurohormonal antagonists? Results of the Copernicus study

✍ Henry Krum; A.J.S. Coats; M.B. Fowler; H.A. Katus; P. Mohasci; J.L. Rouleau; M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Does digitalis influence the response to

Does digitalis influence the response to beta-blockade in patients with severe chronic heart failure? Results of the COPERNICUS study

✍ Alan B. Miller; Christopher O'Connor; Andrew J. Coats; Henry Krum; Michal Tender 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Efficacy and safety of carvedilol in pat

Efficacy and safety of carvedilol in patients with severe chronic heart failure and low systolic blood pressure: results of the COPERNICUS study

✍ Jean L. Rouleau; Michael B. Fowler; Henry Krum; Hugo A. Katus; Andrew J. Coats; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 279 KB

1008-191 Statin therapy is associated wi

1008-191 Statin therapy is associated with a 67 percent reduction in mortality in patients with severe chronic heart failure: Results from the placebo arm of the ENABLE study

✍ Olga Milo; Isaac Kobrin; Aline Frey; Loic Perchenet; Edo Kaluski; Nir Uriel; Ale 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB